Sysmex (OTCMKTS:SSMXY) Posts Earnings Results, Meets Expectations

Sysmex (OTCMKTS:SSMXY) posted its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.10, Zacks reports. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex updated its FY 2026 guidance to 0.415-0.415 EPS.

Sysmex Price Performance

Shares of SSMXY traded up $0.02 during mid-day trading on Tuesday, reaching $13.57. The company had a trading volume of 515 shares, compared to its average volume of 216,702. The company has a market capitalization of $8.25 billion, a price-to-earnings ratio of 32.30 and a beta of 1.20. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.53 and a current ratio of 3.40. The company’s 50 day simple moving average is $12.01 and its 200 day simple moving average is $10.03. Sysmex has a 1-year low of $8.01 and a 1-year high of $13.57.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

About Sysmex

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis.

The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.